ArticleCancers2022

Survival Benefit of Statin with Anti-Angiogenesis Efficacy in Lung Cancer-Associated Pleural Fluid through FXR Modulation.

Chen-Liang Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.